FDA approves Keytruda as adjuvant treatment for kidney cancer
November 18, 2021 at 19:04 PM EST
The cancer immunotherapy drug Keytruda, was approved Thursday by the FDA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|